BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.

Alzheimer's disease (AD), the most common form of dementia, shares many aspects of abnormal brain aging. We present a novel magnetic resonance imaging (MRI)-based biomarker that predicts the individual progression of mild cognitive impairment (MCI) to AD on the basis of pathological brain aging...

Full description

Bibliographic Details
Main Authors:	Christian Gaser, Katja Franke, Stefan Klöppel, Nikolaos Koutsouleris, Heinrich Sauer, Alzheimer's Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3695013?pdf=render

Similar Items

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
by: Luise Christine Löwe, et al.
Published: (2016-01-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
by: Jorge Garcia Condado, et al.
Published: (2023-10-01)

Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
by: Matthew Velazquez, et al.
Published: (2021-01-01)

Ten Years of BrainAGE as a Neuroimaging Biomarker of Brain Aging: What Insights Have We Gained?
by: Katja Franke, et al.
Published: (2019-08-01)

CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia.
by: Pan Fu, et al.
Published: (2022-01-01)

Explainability of random survival forests in predicting conversion risk from mild cognitive impairment to Alzheimer’s disease
by: Alessia Sarica, et al.
Published: (2023-11-01)

Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease.
by: Zhijun Yao, et al.
Published: (2010-11-01)

Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease
by: Aonan Zhao, et al.
Published: (2022-12-01)

Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors.
by: Yue Cui, et al.
Published: (2011-01-01)

Alzheimer's disease: 3‐Dimensional MRI texture for prediction of conversion from mild cognitive impairment
by: Collin C. Luk, et al.
Published: (2018-01-01)

Directed network motifs in Alzheimer's disease and mild cognitive impairment.
by: Eric J Friedman, et al.
Published: (2015-01-01)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
by: Giulia Arenare, et al.
Published: (2023-08-01)

Specific White Matter Tracts and Diffusion Properties Predict Conversion From Mild Cognitive Impairment to Alzheimer’s Disease
by: David B. Stone, et al.
Published: (2021-07-01)

Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion.
by: Han Li, et al.
Published: (2014-01-01)

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment
by: Cosimo Tuena, et al.
Published: (2023-07-01)

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease
by: Yi Chen, et al.
Published: (2021-12-01)

Single‐nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients
by: Eunjee Lee, et al.
Published: (2017-01-01)

Sex Differences in Conversion Risk from Mild Cognitive Impairment to Alzheimer’s Disease: An Explainable Machine Learning Study with Random Survival Forests and SHAP
by: Alessia Sarica, et al.
Published: (2024-02-01)

Association of CSF GAP-43 and <i>APOE</i> ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
by: Yueli Zhu, et al.
Published: (2022-12-01)

Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer’s disease: a feature selection ensemble combining stability and predictability
by: Telma Pereira, et al.
Published: (2018-12-01)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
by: Annie M. Racine, et al.
Published: (2018-01-01)

Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach
by: Xiwu Wang, et al.
Published: (2023-03-01)

Explainable Machine Learning with Pairwise Interactions for Predicting Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Utilizing Multi-Modalities Data
by: Jiaxin Cai, et al.
Published: (2023-10-01)

Brain network construction and analysis for patients with mild cognitive impairment and Alzheimer's disease based on a highly‐available nodes approach
by: Xiaopan Zhang, et al.
Published: (2021-03-01)

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
by: Hucheng Zhou, et al.
Published: (2019-01-01)

Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning
by: Qing Li, et al.
Published: (2018-01-01)

Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
by: Aditi Gupta, et al.
Published: (2020-01-01)

Lower functional hippocampal redundancy in mild cognitive impairment
by: Stephanie Langella, et al.
Published: (2021-01-01)

Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on 18F-FDG PET Imaging
by: Ping Zhou, et al.
Published: (2021-10-01)

A combination of 3-D discrete wavelet transform and 3-D local binary pattern for classification of mild cognitive impairment
by: Harsh Bhasin, et al.
Published: (2020-02-01)

Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementia
by: Diana L. Giraldo, et al.
Published: (2021-01-01)

Information Flow Pattern in Early Mild Cognitive Impairment Patients
by: Haijuan He, et al.
Published: (2021-11-01)

Brain Connectivity Based Prediction of Alzheimer’s Disease in Patients With Mild Cognitive Impairment Based on Multi-Modal Images
by: Weihao Zheng, et al.
Published: (2019-11-01)

Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment
by: Matteo De Marco, et al.
Published: (2023-05-01)

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
by: Eddie Stage, et al.
Published: (2021-01-01)

MRI Asymmetry Index of Hippocampal Subfields Increases Through the Continuum From the Mild Cognitive Impairment to the Alzheimer's Disease
by: Alessia Sarica, et al.
Published: (2018-08-01)

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.
by: Niklas Mattsson, et al.
Published: (2013-01-01)

Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
by: Erika J Lampert, et al.
Published: (2013-01-01)

The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment
by: Silke White, et al.
Published: (2023-07-01)